Ticker

No recent analyst price targets found for HYEX.

Latest News for HYEX

Healthy Extracts Q2 2026 Net Revenue Up 113% to Record $2.1 Million, Driving Adj. EBITDA of $290,000 or $0.02 per Share

Strong Growth Outlook Enhanced by Acquisition of Sommer Ray's Imaraïs Beauty, Bringing a New Global Brand Presence Along with Major National and International B2B Wins 1H-2026 Net Revenues Reached Record $3.7 million, up 94%, with Adj. EBITDA at $254,000    LAS VEGAS, NV / ACCESS Newswire / August 14, 2026 / Healthy Extracts Inc. (OTCQB:HYEX), a leader in nutraceutical formulations and precision dose gummy…

Accesswire • Aug 14, 2026
Healthy Extracts Sees First Half 2026 Net Revenue Up More Than 93% to Record $3.6 Million+

Continued Strong 2026 Outlook Enhanced by Acquisition of Sommer Ray's Imaraïs Beauty, Delivering Major National B2B Customer Wins LAS VEGAS, NV / ACCESS Newswire / August 6, 2026 / Healthy Extracts Inc. (OTCQB:HYEX), a leader in nutraceutical formulations and precision dose gummy manufacturing, expects to report another period of record revenues for the second quarter and first half ended June 30, 2026. Second…

Accesswire • Aug 6, 2026

🧮 Earnings Move Analyzer

Insider Trading

Insider Trading

NameRoleDateTypeSharesPriceFormLink

No Senate trades found for HYEX.

No House trades found for HYEX.

Options Chain

Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.

Scroll to Top